Saturday, September 19, 2020

Drug Controller Approves Commercial Launch Of Low Cost Covid Test Feluda

The Drugs Controller General of India has approved the commercial launch of "Feluda", the Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) COVID-19 test, the Council of...

from NDTV News - Topstories https://ift.tt/2FMnI1j

No comments:

Post a Comment

Popcorn Time Updater Flaw Put Up to 350,000 Macs at Risk, Researchers Warn

Cybersecurity researchers at Eye Research found a vulnerability in Time4Popcorn, an unofficial version of Popcorn Time, that could allow att...